Some pharma companies have started to improve the procurement capabilities that support TechOps, mainly by deploying digital technology, but most are still far from matching their peers in other adjacent industries.
For a variety of reasons, pharma firms have been slow to radically upgrade procurement. Once a company selects a product platform, its costs are generally locked in throughout the product life cycle. This makes it hard to change the approach to procuring products in specific categories and managing suppliers.
If a company does make changes to its supply chain, it may need to address regulatory compliance issues and adjust quality requirements—which, again, creates obstacles to doing things differently.
For some direction, pharma companies can look to the approaches that other industries have already successfully applied to optimise costs and minimise risks in the supply chain.
How important is TechOps in your pharma company?
#TechOps #PharmaCompanies #Procurement
Follow us on LinkedIn for more insights
